Alprazolam, a triazolobenzodiazepine, was successfully used to treat a patient with recent cardiac disease who presented with DST-positive endogenous depression. The relative absence of cardiotoxic effects warrants the consideration of this medication in cardiac patients with concurrent anxiety and/or depression.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
endogenous depression
8
patient cardiac
8
cardiac disease
8
successful treatment
4
treatment endogenous
4
depression alprazolam
4
alprazolam patient
4
disease case
4
case report
4
report alprazolam
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!